Report Detail
Global Pulmonary Drug Delivery Systems Market Growth 2019-2024
- RnM2872653 |
- 04 February, 2019 |
- Global |
- 162 Pages |
- LPI(LP Information) |
- Other
Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.
As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.
According to this study, over the next five years the Pulmonary Drug Delivery Systems market will register a 5.3% CAGR in terms of revenue, the global market size will reach US$ 3490 million by 2024, from US$ 2560 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pulmonary Drug Delivery Systems business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Drug Delivery Systems market by product type, application, key manufacturers and key regions and countries.
This study considers the Pulmonary Drug Delivery Systems value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
COPD
Asthma
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pulmonary Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pulmonary Drug Delivery Systems market by identifying its various subsegments.
Focuses on the key global Pulmonary Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pulmonary Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pulmonary Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Pulmonary Drug Delivery Systems Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pulmonary Drug Delivery Systems Consumption 2014-2024
- 2.1.2 Pulmonary Drug Delivery Systems Consumption CAGR by Region
- 2.2 Pulmonary Drug Delivery Systems Segment by Type
- 2.2.1 Nebulizers
- 2.2.2 Dry Powder Inhaler (DPI)
- 2.2.3 Metered Dose Inhaler (MDI)
- 2.3 Pulmonary Drug Delivery Systems Consumption by Type
- 2.3.1 Global Pulmonary Drug Delivery Systems Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Pulmonary Drug Delivery Systems Sale Price by Type (2014-2019)
- 2.4 Pulmonary Drug Delivery Systems Segment by Application
- 2.4.1 COPD
- 2.4.2 Asthma
- 2.4.3 Others
- 2.5 Pulmonary Drug Delivery Systems Consumption by Application
- 2.5.1 Global Pulmonary Drug Delivery Systems Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Pulmonary Drug Delivery Systems Value and Market Share by Application (2014-2019)
- 2.5.3 Global Pulmonary Drug Delivery Systems Sale Price by Application (2014-2019)
3 Global Pulmonary Drug Delivery Systems by Players
- 3.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Players
- 3.1.1 Global Pulmonary Drug Delivery Systems Sales by Players (2017-2019)
- 3.1.2 Global Pulmonary Drug Delivery Systems Sales Market Share by Players (2017-2019)
- 3.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Players
- 3.2.1 Global Pulmonary Drug Delivery Systems Revenue by Players (2017-2019)
- 3.2.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Players (2017-2019)
- 3.3 Global Pulmonary Drug Delivery Systems Sale Price by Players
- 3.4 Global Pulmonary Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Pulmonary Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Pulmonary Drug Delivery Systems Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Pulmonary Drug Delivery Systems by Regions
- 4.1 Pulmonary Drug Delivery Systems by Regions
- 4.1.1 Global Pulmonary Drug Delivery Systems Consumption by Regions
- 4.1.2 Global Pulmonary Drug Delivery Systems Value by Regions
- 4.2 Americas Pulmonary Drug Delivery Systems Consumption Growth
- 4.3 APAC Pulmonary Drug Delivery Systems Consumption Growth
- 4.4 Europe Pulmonary Drug Delivery Systems Consumption Growth
- 4.5 Middle East & Africa Pulmonary Drug Delivery Systems Consumption Growth
5 Americas
- 5.1 Americas Pulmonary Drug Delivery Systems Consumption by Countries
- 5.1.1 Americas Pulmonary Drug Delivery Systems Consumption by Countries (2014-2019)
- 5.1.2 Americas Pulmonary Drug Delivery Systems Value by Countries (2014-2019)
- 5.2 Americas Pulmonary Drug Delivery Systems Consumption by Type
- 5.3 Americas Pulmonary Drug Delivery Systems Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Pulmonary Drug Delivery Systems Consumption by Countries
- 6.1.1 APAC Pulmonary Drug Delivery Systems Consumption by Countries (2014-2019)
- 6.1.2 APAC Pulmonary Drug Delivery Systems Value by Countries (2014-2019)
- 6.2 APAC Pulmonary Drug Delivery Systems Consumption by Type
- 6.3 APAC Pulmonary Drug Delivery Systems Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Pulmonary Drug Delivery Systems by Countries
- 7.1.1 Europe Pulmonary Drug Delivery Systems Consumption by Countries (2014-2019)
- 7.1.2 Europe Pulmonary Drug Delivery Systems Value by Countries (2014-2019)
- 7.2 Europe Pulmonary Drug Delivery Systems Consumption by Type
- 7.3 Europe Pulmonary Drug Delivery Systems Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Pulmonary Drug Delivery Systems by Countries
- 8.1.1 Middle East & Africa Pulmonary Drug Delivery Systems Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Pulmonary Drug Delivery Systems Value by Countries (2014-2019)
- 8.2 Middle East & Africa Pulmonary Drug Delivery Systems Consumption by Type
- 8.3 Middle East & Africa Pulmonary Drug Delivery Systems Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Pulmonary Drug Delivery Systems Distributors
- 10.3 Pulmonary Drug Delivery Systems Customer
11 Global Pulmonary Drug Delivery Systems Market Forecast
- 11.1 Global Pulmonary Drug Delivery Systems Consumption Forecast (2019-2024)
- 11.2 Global Pulmonary Drug Delivery Systems Forecast by Regions
- 11.2.1 Global Pulmonary Drug Delivery Systems Forecast by Regions (2019-2024)
- 11.2.2 Global Pulmonary Drug Delivery Systems Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Pulmonary Drug Delivery Systems Forecast by Type
- 11.8 Global Pulmonary Drug Delivery Systems Forecast by Application
12 Key Players Analysis
- 12.1 3M
- 12.1.1 Company Details
- 12.1.2 Pulmonary Drug Delivery Systems Product Offered
- 12.1.3 3M Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 3M News
- 12.2 GSK
- 12.2.1 Company Details
- 12.2.2 Pulmonary Drug Delivery Systems Product Offered
- 12.2.3 GSK Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 GSK News
- 12.3 AstraZeneca
- 12.3.1 Company Details
- 12.3.2 Pulmonary Drug Delivery Systems Product Offered
- 12.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 AstraZeneca News
- 12.4 Cipla
- 12.4.1 Company Details
- 12.4.2 Pulmonary Drug Delivery Systems Product Offered
- 12.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Cipla News
- 12.5 Chiesi
- 12.5.1 Company Details
- 12.5.2 Pulmonary Drug Delivery Systems Product Offered
- 12.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Chiesi News
- 12.6 Boehringer Ingelheim
- 12.6.1 Company Details
- 12.6.2 Pulmonary Drug Delivery Systems Product Offered
- 12.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Boehringer Ingelheim News
- 12.7 Aptar
- 12.7.1 Company Details
- 12.7.2 Pulmonary Drug Delivery Systems Product Offered
- 12.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Aptar News
- 12.8 Novartis
- 12.8.1 Company Details
- 12.8.2 Pulmonary Drug Delivery Systems Product Offered
- 12.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Novartis News
- 12.9 Philips Respironics
- 12.9.1 Company Details
- 12.9.2 Pulmonary Drug Delivery Systems Product Offered
- 12.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Philips Respironics News
- 12.10 Omron Healthcare
- 12.10.1 Company Details
- 12.10.2 Pulmonary Drug Delivery Systems Product Offered
- 12.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Omron Healthcare News
- 12.11 PARI
- 12.12 Skyepharma
- 12.13 CareFusion
- 12.14 Shanghai Huarui
- 12.15 Taian Character
- 12.16 Chia Tai Tianqing
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pulmonary Drug Delivery Systems . Industry analysis & Market Report on Pulmonary Drug Delivery Systems is a syndicated market report, published as Global Pulmonary Drug Delivery Systems Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Pulmonary Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
